We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$302B
AUM Growth
+$34.6B
Cap. Flow
+$23B
Cap. Flow %
7.61%
Top 10 Hldgs %
17.01%
Holding
3,993
New
281
Increased
2,296
Reduced
1,151
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Financials 13.67%
3 Healthcare 11.47%
4 Consumer Discretionary 11.19%
5 Communication Services 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SENS icon
3651
Senseonics Holdings Inc
SENS
$254M
$108K ﹤0.01%
+1,311
New +$94K
CDMO
3652
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$108K ﹤0.01%
+27,430
New +$95.2K
TDW.WS.A
3653
DELISTED
Tidewater Inc. Series A Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.A
$107K ﹤0.01%
30,634
ZIXI
3654
DELISTED
Zix Corporation
ZIXI
$105K ﹤0.01%
19,393
-28,309
-59% -$146K
MNOV icon
3655
MediciNova
MNOV
$63.5M
$104K ﹤0.01%
+13,034
New +$135K
HBIO icon
3656
Harvard Bioscience
HBIO
$27.6M
$103K ﹤0.01%
1,925
+924
+92% +$47.3K
DZSI
3657
DELISTED
DZS Inc. Common Stock
DZSI
$101K ﹤0.01%
+10,366
New +$109K
SRRA
3658
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$100K ﹤0.01%
845
+282
+50% +$28.3K
UEC icon
3659
Uranium Energy
UEC
$4.47B
$99K ﹤0.01%
61,429
+45,095
+276% +$71.6K
HD icon
3660
CALL
Home Depot
HD
$337B
$98K ﹤0.01%
500
LLEX
3661
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$96K ﹤0.01%
+18,392
New +$86K
SBBP
3662
DELISTED
Strongbridge Biopharma plc.
SBBP
$95K ﹤0.01%
15,780
-24,401
-61% -$179K
DERM
3663
DELISTED
Dermira, Inc.
DERM
$95K ﹤0.01%
10,322
-522,102
-98% -$4.87M
TDW.WS.B
3664
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$92K ﹤0.01%
33,117
NSLR
3665
Neostellar Capital Corp
NSLR
$258M
$90K ﹤0.01%
+15,665
New +$92K
CPRX
3666
DELISTED
Catalyst Pharmaceutical
CPRX
$89K ﹤0.01%
+28,558
New +$86.6K
CTIC
3667
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$88K ﹤0.01%
+17,633
New +$77.2K
UUUU icon
3668
Energy Fuels
UUUU
$2.68B
$84K ﹤0.01%
+36,924
New +$72.8K
HDSN
3669
Hudson Technologies
HDSN
$246M
$83K ﹤0.01%
41,467
-23,028
-36% -$74.6K
LCTX icon
3670
Lineage Cell Therapeutics
LCTX
$264M
$80K ﹤0.01%
44,555
-77,279
-63% -$156K
DRRX
3671
DELISTED
DURECT Corp
DRRX
$76K ﹤0.01%
+4,848
New +$99.4K
AVEO
3672
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$76K ﹤0.01%
+3,365
New +$79.8K
NETS
3673
DELISTED
Netshoes (Cayman) Limited
NETS
$72K ﹤0.01%
30,435
+208
+0.7% +$816
UTSI icon
3674
UTStarcom
UTSI
$22M
$70K ﹤0.01%
+4,316
New +$80.8K
ENZ
3675
DELISTED
Enzo Biochem, Inc.
ENZ
$67K ﹤0.01%
+12,822
New +$78.1K

Similar funds

Invesco's Q2 2018 Portfolio in Review

As of Q2 2018, Invesco held 3,993 positions worth $302B, up 13% from $268B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco deployed $23B of net new capital in Q2 2018, opening 281 new positions and adding to 2,296 existing holdings. Its largest new stake was Invesco Short Term Treasury ETF: 4,268,300 shares worth $453M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vodafone, an estimated $205M trimmed.

  • Invesco's largest Q2 2018 buy was Invesco Short Term Treasury ETF: 4,268,300 shares worth $453M.
  • Invesco added most to Amazon in Q2 2018, an estimated $389M increase.
  • Invesco's biggest Q2 2018 reduction was Vodafone, cutting an estimated $205M.
  • Invesco fully exited PowerShares Treasury Collateral Portfolio in Q2 2018, selling an estimated $451M.
  • Invesco's ten largest holdings make up 17% of its $302B portfolio in Q2 2018.
  • Invesco opened 281 new positions and closed 120 in Q2 2018.
  • Invesco's portfolio value rose 13% quarter-over-quarter to $302B.

Based on Invesco's 13F filing for Q2 2018, filed 14 Aug 2018.